Hành Vi Phụ Thuộc ở Bệnh Nhân Đau Đầu Do Lạm Dụng Thuốc

•• Halker RB, Hastriter EV, Dodick DW. Chronic Daily Headache: An Evidence-Based and Systematic Approach to a Challenging Problem. Neurology 2011;76(72): S37–S43. This is a good review of chronic daily headache. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd ed. Cephalalgia. 2004;24 Suppl 1:1–160. Silberstein SD, Olesen J, Bousser MG, et al. The international classification of headache disorders, 2nd edition (ICHD-II)–revision of criteria for 8.2 medication-overuse headache. Cephalalgia. 2005;25:460–5. • Meng ID, Dodick D, Ossipov MH, Porreca F. Pathophysiology of medication overuse headache: Insights and hypotheses from preclinical studies. Cephalalgia 2011;31:851–860. This is a good review of the pathophysiology of medication-overuse headache. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol. 2004;3:475–83. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994 Martin CS, Chung T, Langenbucher JW. How should we revise diagnostic criteria for substance use disorders in the DSM-V? J Abnorm Psychol. 2008;117:561–75. •• Radat F, Lanteri-Minet M. What is the role of dependence-related behavior in medication-overuse headache? Headache. 2010; 50:1597–1611. This is a comprehensive review of the relationship between dependence and medication overuse headache. Saper JR, Jones JM. Ergotamine tartrate dependency: features and possible mechanisms. Clin Neuropharmacol. 1986;9:244–56. Schnider P, Aull S, Baumgartner C, et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: Five-year follow-up. Cephalalgia. 1996;16:481–5. Katsarava Z, Limmroth V, Finke M, et al. Rates and predictors for relapse in medication overuse headache: A 1-year prospective study. Neurology. 2003;60:1682–3. Katsarava Z, Muessig M, Dzagnidze A, et al. Medication overuse headache: Rates and predictors for relapse in a 4-year prospective study. Cephalalgia. 2005;25:12–5. Rossi P, Faroni JV, Nappi G. Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia. 2008;28:1196–200. Fuh JL, Wang SJ, Lu SR, Juang KD. Does medication overuse headache represent a behavior of dependence? Pain. 2005;119:49–55. Radat F, Creach C, Guegan-Massardier E, et al. Behavioral dependence in patients with medication overuse headache: A cross-sectional study in consulting patients using the DSM-IV criteria. Headache. 2008;48:1026–36. Radat F, Irachabal S, Lafittau M, et al. Construction of a medication dependence questionnaire in headache patients (MDQ-H) validation of the French version. Headache. 2006;46:233–9. Raistrick D, Bradshaw J, Tober G, et al. Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package. Addiction. 1994;89:563–72. Gossop M, Darke S, Griffiths P, et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90:607–14. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: WHO; 1992. Ferrari A, Cicero AFG, Bertolini A, et al. Need for analgesics/drugs of abuse: A comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). Cephalalgia. 2005;26:187–93. Haag G. LDQ—validated for headache diseases? Cephalalgia. 2010;30:254–5. • Lundqvist C, Benth JŠ, Grande RB, et al. An adapted Severity of Dependence Scale is valid for the detection of medication overuse: the Akershus study of chronic headache. Eur J Neurol. 2011; 18:512–518. This article offers an instrument for the detection of medication overuse in headache patients. • Grande RB, Aaseth K, Šaltyte-Benth J, et al. The severity of dependence scale detects people with medication overuse. The Akershus study of chronic headache. J Neurol Neurosurg Psychiatry 2009; 80:784–789. This article provides data for a dependence scale for the detection of medication overuse in chronic headache patients. • Lundqvist C, Aaseth K, Grande RB, et al. The severity of dependence score correlates with medication overuse in persons with secondary chronic headaches. The Akershus study of chronic headache. Pain 2010; 148:487–491. This article provides data for a dependence scale for the detection of medication overuse in secondary chronic headache patients. Martins SS, Gorelick DA. Conditional substance abuse and dependence by diagnosis of mood or anxiety disorder or schizophrenia in the U.S. population. Drug Alcohol Depend. 2011, doi:10.1016/j.drugalcdep.2011.05.010. Torres AR, Prince MJ, Bebbington PE, et al. Obsessive-compulsive disorder: Prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. Am J Psychiatry. 2006;163:1978–85. Cupini LM, De Murtas M, Costa C, et al. Obsessive-compulsive disorder and migraine with medication-overuse headache. Headache. 2009;49:1005–13. Bigal ME, Sheftell FD, Rapoport AM, et al. MMPI personality profiles in patients with primary chronic daily headache: a case–control study. Neurol Sci. 2003;24:103–10. Sances G, Galli F, Anastasi S, et al. Medication-overuse headache and personality: a controlled study by means of the MMPI-2. Headache. 2010;50:198–209. Atasoy HT, Atasoy N, Unal AE, et al. Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache. Eur J Pain. 2005;9:285–91. Swendsen J, Conway KP, Degenhardt L, et al. Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction. 2010;105:1117–28. Saper JR, Lake 3rd AE. Medication overuse headache: type I and type II. Cephalalgia. 2006;26:1262. •• Büttner A. Review: The neuropathology of drug abuse. Neuropathology and Applied Neurobiology 2011;37:118–134. This is a good review of the neuropathology of drug abuse. Fumal A, Laureys S, Di Clemente L, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. 2006;129:543–50. •• Cupini LM, Sarchielli P, Calabresi P. Medication overuse headache: neurobiological, behavioural and therapeutic aspects. Pain 2010; 150: 222–224. This is a comprehensive review of medication-overuse headache. Cevoli S, Mochi M, Scapoli C, et al. A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol. 2006;13:1009–13. Di Lorenzo C, Sances G, Di Lorenzo G, et al. The wolframin His611Arg polymorphism influences medication overuse headache. Neurosci Lett. 2007;424:179–84. Chou CH, Fuh JL, Wu JC, Wang SJ. Comparison of self-reported cutaneous allodynia and brushing allodynia during migraine attacks. Cephalalgia. 2010;30:682–5. •• De Felice M, Ossipov MH, Wang R, et al. Triptan-induced latent sensitization: A possible basis for medication overuse headache. Annals of Neurology 2010; 67: 325–337. This is an important study of the mechanism underlying medication overuse headache. Russo EB. Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinol Lett. 2004;25:31–9. Sarchielli P, Pini LA, Coppola F, et al. Endocannabinoids in chronic migraine: CSF findings suggest a system failure. Neuropsychopharmacology. 2007;32:1384–90. Rossi C, Pini LA, Cupini ML, et al. Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. Eur J Clin Pharmacol. 2008;64:1–8. • Chiou LC, Lee HJ, Ho YC, et al. Orexins/Hypocretins: Pain Regulation and Cellular Actions. Current Pharmaceutical Design 2010; 16:3089–3100. This is a good review of the role of Orexins in pain modulation. Mallet C, Daulhac L, Bonnefont J, et al. Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain. 2008;139:190–200. • Bigal ME, Lipton RB. Excessive opioid use and the development of chronic migraine. Pain 2009; 142:179–182. This is a good review of the evidence of opioids inducing chronic migraine. Sarchielli P, Rainero I, Coppola F, et al. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid. Cephalalgia. 2008;28:714–22. • Lauwerier E, Paemeleire K, Van Damme S, et al. Medication use in patients with migraine and medication-overuse headache: The role of problem-solving and attitudes about pain medication. Pain 2011; 152:1334–9. This paper offers evidence of the role of coping skills in medication overuse headache. Bigal M, Lipton R. Excessive acute migraine medication use and migraine progression. Neurology. 2008;25:1821–8. •• Fritsche G, Frettloh J, Huppe M, et al. Prevention of medication overuse in patients with migraine. Pain 2010; 151:404–413. This article provides evidence to support the use of behavioral therapy in preventing the development of medication overuse headache.